Truist Securities Maintains Buy on Molina Healthcare, Lowers Price Target to $400
Portfolio Pulse from Benzinga Newsdesk
Truist Securities analyst David Macdonald maintains a Buy rating on Molina Healthcare (NYSE:MOH) but lowers the price target from $440 to $400.
July 15, 2024 | 2:06 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Truist Securities has maintained its Buy rating on Molina Healthcare but has lowered the price target from $440 to $400.
The maintained Buy rating suggests continued confidence in Molina Healthcare's performance, but the lowered price target indicates some caution regarding its short-term growth potential. This mixed signal is likely to result in a neutral short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100